Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Russia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20063
20071
20083
20091
20102
20113
20121
20131
20163
20171
20181
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S5
Eli Lilly and Company4
Sanofi4
AstraZeneca3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Janssen Research & Development, LLC2
Takeda2
GlaxoSmithKline1
Intra-Cellular Therapies, Inc.1
Naurex, Inc, an affiliate of Allergan plc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder27
Depressive Disorder7
Mood Disorders5
Mental Disorders4
Bipolar Disorder1
Dysthymic Disorder1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.